| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 04/26/2005 | US6884808 Acids and salts such as 4-(4-(2-(2-(5,6,7,8-Tetrahydro-5,5,8, 8-tetramethylquinoxalyl))pyrrolyl))benzoic acid, used retinoic acid receptor agonists for the prophylaxis of cancer, skin disorders, asthma, alopecia or autoimmune diseases |
| 04/26/2005 | US6884806 Treatment of rheumatoid and osteoarthritis, corneal, epidermal or gastric ulceration, tumor metastasis, periodontal disease, bone disease |
| 04/26/2005 | US6884803 Phenylalkynes |
| 04/26/2005 | US6884477 Electroluminescence device using liquid crystal compound |
| 04/26/2005 | US6884408 Delivery of diphenhydramine through an inhalation route |
| 04/26/2005 | CA2209487C Imidazo[4,5-c]quinoline amines |
| 04/21/2005 | WO2005035533A1 Modulators of serotonin receptors |
| 04/21/2005 | WO2005035524A1 Pyrrolidinyl urea derivatives as angiogensis inhibitors |
| 04/21/2005 | WO2005035518A1 Rearranged pentanols, a method for the production thereof, and their use as antiphlogistics |
| 04/21/2005 | WO2005035501A1 Novel olefin derivative |
| 04/21/2005 | WO2005034869A2 Compounds and compositions as protein kinase inhibitors |
| 04/21/2005 | WO2005034866A2 Preparation of 1, 6, 7- trisubstituted azabenzimidazoles as kinase inhibitors |
| 04/21/2005 | WO2005034838A2 Protease inhibitors |
| 04/21/2005 | WO2005023807A3 4 - heterobicyclyamino - substituted quinazolines and analogues therof as capsaicin - antagonists |
| 04/21/2005 | WO2005004801A3 Indole, azaindole and related heterocyclic n-substituted piperazine derivatives |
| 04/21/2005 | WO2004111047A3 Cycloalkanepyrrolopyridines as dp receptor antagonists |
| 04/21/2005 | WO2004110992A3 Process for imidazo[4,5-c] pyridin-4-amines |
| 04/21/2005 | WO2004080398A3 1-amino 1h-imidazoquinolines |
| 04/21/2005 | WO2004026863A8 Novel oxazole and thiazole compounds as transforming growth factor (tgf) inhibitors |
| 04/21/2005 | US20050085531 Thiophene-based compounds exhibiting ATP-utilizing enzyme inhibitory activity, and compositions, and uses thereof |
| 04/21/2005 | US20050085507 p-phenylethenyl hydroxamates; anticarcinogenic, antitumor, antiproliferative agents; regulating p21 promoter; improved stability |
| 04/21/2005 | US20050085502 Phenyl-substituted imidazopyridines |
| 04/21/2005 | US20050085501 Phenyl-substituted imidazopyridines |
| 04/21/2005 | US20050085500 Reacting arylmethylamine with 4-chloro-1H-imidazolo(4,5-c)quinoline |
| 04/21/2005 | US20050085492 Glycinamide ribonucleotide formyl transferase inhibitor |
| 04/21/2005 | US20050085490 Pyridino[1,2-a]pyrimidin-4-one compounds as anticancer agents |
| 04/21/2005 | US20050085481 1-(aminoalkyl)-3-sulfonylazaindoles as 5-hydroxytryptamine-6 ligands |
| 04/21/2005 | US20050085476 Polymerase inhibitors; antiischemic agents; brain disorders; cardiovascular disorders; antiinflammatory agents; antiarthritic agents; neurodegenerative agents; Alzheimer's disease; muscular disorders; antidiabetic agents; kidney disorders; viricides; anticancer agents; immunosuppressants |
| 04/21/2005 | US20050085471 Using 2-morpholinyl-4H-pyrido(1,2-a)pyrimidin-4-one; enzyme inhibitors; antithrombotic agents ; restenosis; atherosclerosis; antihistamines; chronic obsessive pulminary disease; autoimmune diseases; anticancer agents; antiinflammatory agents |
| 04/21/2005 | US20050085465 Quinazoline compounds |
| 04/21/2005 | US20050085460 useful as therapeutics in treatment of cancers and the amelioration of the effects of stroke, head trauma, and neurodegenerative disease |
| 04/21/2005 | US20050085447 Osteoarthritis; rheumatic disorders ; psoriasis; anklosing spondylitis; atherosclerosis; inflammatory bowel disorders; multiple sclerosis; congestive heart failure; vision defects; chronic obstructive pulmonary disease; asthma; oral diseases; psoriasis; cancer |
| 04/21/2005 | US20050084451 Novel chelating agents and chelates and their use |
| 04/21/2005 | US20050083391 Azo dye, image-forming coloring composition, ink for ink jet recording, heat-sensitive recording material, color toner and color filter |
| 04/21/2005 | CA2540868A1 Pyrrolidinyl urea derivatives as angiogenesis inhibitors |
| 04/21/2005 | CA2539878A1 Rearranged pentanols, a method for the production thereof, and their use as antiphlogistics |
| 04/20/2005 | EP1523778A2 Heteroatom-containing diamondoid transistors |
| 04/20/2005 | EP1523482A1 Ligand and complex for catalytically bleaching a substrate |
| 04/20/2005 | EP1349847B1 Oxybenzamides derivatives as factor xa inhibitors |
| 04/20/2005 | EP1042287B1 Indole derivatives as inhibitors of factor xa |
| 04/20/2005 | EP0984947B1 Oxazolidinone antibacterial agents having a thiocarbonyl functionality |
| 04/20/2005 | EP0766669B1 Tri-substituted phenyl derivatives useful as pde iv inhibitors |
| 04/20/2005 | CN1608069A Selective androgen receptor modulators and methods for their identification, design and use |
| 04/20/2005 | CN1608068A Bridged bicyclic amino acid-derived [1, 4]benzodiazepine vasopressin receptor antagonists |
| 04/20/2005 | CN1608065A Phenyl substituted triazoles and their use as selective inhibors of akl5 kinase and pharmaceutical compositions containing the compounds |
| 04/20/2005 | CN1197863C Novel octahydro-2H-pyridino-[1, 2-a] pyrazine compound, its prepn. process and medicinal compound contg. them |
| 04/20/2005 | CN1197860C FAB I inhibitors |
| 04/20/2005 | CN1197620C Use of immidazoquinolinamines as adjuvants in DNA vaccination |
| 04/20/2005 | CN1197578C Pharmaceutical suspension comprising nevirapine hemihydrate |
| 04/20/2005 | CN1197458C Herbicidal synergic composition and method for controlling weed |
| 04/19/2005 | US6881842 Chemical intermediate for making acetylcholinesterase enzyme inhibitors 8-(3-(1-((3-fluorophenyl)methyl)-4-piperidinyl)-1-oxopropyl)-1,2,5,6 -tetrahydro-4H-pyrrolo (3,2,1-ij)quinoline-4-one |
| 04/19/2005 | US6881741 Such as 3-(4-Chloro-2,5-dimethyl-benzenesulfonylamino)-5-(4-chloro-phenyl)-thiophene-2-carboxylic acid; for treatment of hepatitis |
| 04/19/2005 | US6881736 Inhibit the vitronectin receptor and are useful for the treatment of inflammation, cancer and cardiovascular disorders, such as atherosclerosis and restenosis, and diseases wherein bone resorption is a factor, such as |
| 04/19/2005 | US6881734 Pharmaceutical composition for the treatment of CNS and other disorders |
| 04/19/2005 | CA2315189C Integrin receptor antagonists |
| 04/14/2005 | WO2005033108A1 7-amino alkylidenyl-heterocyclic quinolones and naphthyridones |
| 04/14/2005 | WO2005033107A1 Imidazopyridine substituted tropane derivatives with ccr5 receptor antagonist activity for the treatment of hiv and inflammation |
| 04/14/2005 | WO2005033102A2 Thiophene-based compounds exhibiting atp-utilizing enzyme inhibitory activity, and compositions, and uses thereof |
| 04/14/2005 | WO2005033077A1 Sequence selective pyrrole and imidazole polyamide metallocomplexes |
| 04/14/2005 | WO2005033073A2 Spirocyclic heterocyclic derivatives and methods of their use |
| 04/14/2005 | WO2005033049A2 METHOD OF PREPARING 4-AMINO-1H-IMIDAZO(4,5-c)QUINOLINES AND ACID ADDITION SALTS THEREOF |
| 04/14/2005 | WO2005032484A2 Alkoxy substituted imidazoquinolines |
| 04/14/2005 | WO2005032481A2 Quinazoline derivatives as medicaments |
| 04/14/2005 | WO2005013892A9 Hydrolytically-resistant boron-containing therapeutics and methods of use |
| 04/14/2005 | WO2005007099A3 Pkb inhibitors as anti-tumor agents |
| 04/14/2005 | WO2005002503A3 Asymmetric benzimidazoles and related compounds as potassium channel modulators |
| 04/14/2005 | WO2004113391A3 Improved pharmaceutical drug candidates and methods for preparation thereof |
| 04/14/2005 | WO2004100891A3 Cytotoxic indeno and isoindoloisoquinolones |
| 04/14/2005 | WO2004091542A3 Nitrogen containing integrin targeting compounds |
| 04/14/2005 | US20050080138 Mediators of hedgehog signaling pathways, compositions and uses related thereto |
| 04/14/2005 | US20050080116 Compounds useful as motilin agonists and method |
| 04/14/2005 | US20050080096 Condensed heterocyclic compounds |
| 04/14/2005 | US20050080090 Such as 7-(Imidazolo[4,5-b]pyridin-1-yl)-1-(1-methylpyrrolidin-3-yl)naphthalene; for treating depression, anxiety, eating disorders, drug abuse, cluster headache, migraine, pain, and other disorders arising from deficient serotonergic neurotransmission |
| 04/14/2005 | US20050080074 Such as (+-)-1,3,4,10b-tetrahydro-7-trifluoromethoxy-pyrazino[2,1-a]isoindol-6(2H)-one for treatment of metabolic disorders, central nervous system disorders, and gastrointestinal disorders |
| 04/14/2005 | US20050079387 Imidazole ring-containing compound and organic electroluminescence display device |
| 04/14/2005 | US20050079381 Rubrene derivatives emit blue light; glass substrate supports a hole injecting layer, a hole transporting layer, and a light emitting layer |
| 04/14/2005 | US20050079176 Treating stress response with chemokine receptor ccr5 modulators |
| 04/14/2005 | DE10343098A1 Tetrahydrochinoxaline und ihre Verwendung Tetrahydroquinoxalines and their use |
| 04/14/2005 | CA2541014A1 Spirocyclic heterocyclic derivatives and methods of their use |
| 04/14/2005 | CA2539748A1 Substituted benzazoles and use thereof as inhibitors of raf kinase |
| 04/14/2005 | CA2536530A1 Method of preparing 4-amino-1h-imidazo(4,5-c)quinolines and acid addition salts thereof |
| 04/13/2005 | EP1522314A1 Remedies for diseases caused by vascular contraction or dilation |
| 04/13/2005 | EP1521828A2 Production of polyketides |
| 04/13/2005 | EP1521809A1 Oxidation process for preparing quinacridone pigments |
| 04/13/2005 | EP1521757A1 Novel tricyclic spiropiperidines or spiropyrrolidines |
| 04/13/2005 | EP1521754A2 Viral inhibitors |
| 04/13/2005 | EP1521747A2 Receptor-type kinase modulators and methods of use |
| 04/13/2005 | EP1521583A1 7,8,9,10-tetrahydro-6h-azepino, 6,7,8,9-tetrahydro-pyrido and 2,3-dihydro-2h-pyrrolo (2,1-b)-quinazolinone derivatives |
| 04/13/2005 | EP1366050B1 Condensed pyrazindione derivatives as pde inhibitors |
| 04/13/2005 | EP1289955B1 Piperidines for use as orexin receptor antagonists |
| 04/13/2005 | EP1134222B1 IMIDAZO[4,5-b]PYRIDINIUMMETHYL-CONTAINING CEPHEM COMPOUNDS HAVING BROAD ANTIBACTERIAL SPECTRUM |
| 04/13/2005 | CN1606556A Triazolo-quinolin derivatives useful as adenosine receptor ligands |
| 04/13/2005 | CN1606555A Imidazoquinoline derivatives |
| 04/13/2005 | CN1606553A Oxytocin agonistenoxytocin agonisten |
| 04/13/2005 | CN1606545A Pyrrolidine and piperidine derivates as nk1 antagonists |
| 04/13/2005 | CN1606442A Treatments for restless legs syndrome |
| 04/13/2005 | CN1196702C Bicyclic polyaminoacid metal complexes, method for preparing same and use in medical imaging |
| 04/13/2005 | CN1196692C Substituted benzopyran derivatives for the treatment of inflammation |
| 04/13/2005 | CN1196683C Amino-compound |
| 04/13/2005 | CN1196487C 单位剂量形式 The unit dosage form |